[68Ga]CBP8
- Generic Name
- [68Ga]CBP8
Advanced Imaging for Pulmonary Fibrosis
Phase 2
Recruiting
- Conditions
- Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Peter Caravan
- Target Recruit Count
- 60
- Registration Number
- NCT06532071
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Collagen-targeted PET Imaging for Early Interstitial Lung Disease
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05417776
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Phase 2
Recruiting
- Conditions
- Lung CancerRadiation FibrosisRadiation Induced Lung InjuryPancreas Cancer
- Interventions
- First Posted Date
- 2020-07-24
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT04485286
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
Phase 1
Recruiting
- Conditions
- Pulmonary FibrosisLung Cancer
- Interventions
- Diagnostic Test: PET Imaging
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03535545
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath